GMED Globus Medical
Globus Medical earnings company data as of 2:27 PM ET 11/13
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 5 Nov | EPS | 1.20 | 1.23 | Beat +2.5% |
| Rev | $792.5M | $763.7M | Miss -3.6% |
Insider trades
Open-market buys and sales by GMED's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $9.6M sold by 3 insiders outside a trading plan
- $6.5M sold by 4 insiders under 10b5-1 plans
-
James R. Tobin DirectorSale$3.1M 41,666 shares at $75.16 100% of stakeTraded Nov 10 Filed Nov 12
-
Ann D. Rhoads DirectorPlanned sale$425K 5,000 shares at $85.00 12% of stakeTraded Nov 4 Filed Nov 5
-
James R. Tobin DirectorSale$2.2M 30,000 shares at $74.58 100% of stakeTraded Sep 15 Filed Sep 16
-
Stephen T. Zarrilli DirectorSale$2.2M 25,000 shares at $87.04 100% of stakeTraded Aug 18 Filed Aug 19
-
David D. Davidar DirectorSale$2M 25,000 shares at $80.76 4.7% of stakeTraded Jun 5 Filed Jun 9
-
Kelly Huller EVP, GC, Corporate SecretaryPlanned sale$1.9M 20,000 shares at $94.50 100% of stakeTraded Feb 25 Filed Feb 27
-
Kelly Huller EVP, GC, Corporate SecretaryPlanned sale$877K 10,000 shares at $87.67 100% of stakeTraded Feb 12 Filed Feb 17
-
Kyle Kline CFOPlanned sale$363K 3,594 shares at $101.10 100% of stakeTraded Jan 8 Filed Jan 12
-
Leslie V. Norwalk DirectorPlanned sale$202K 2,000 shares at $101.10 16% of stakeTraded Jan 8 Filed Jan 12
-
Leslie V. Norwalk DirectorPlanned sale$355K 4,000 shares at $88.85 24% of stakeTraded Dec 12, 2025 Filed Dec 16, 2025
-
Kyle Kline CFOPlanned sale$1.7M 18,542 shares at $90.00 100% of stakeTraded Dec 1, 2025 Filed Dec 3, 2025
-
Kelly Huller SVP, GC, Corporate SecretaryPlanned sale$675K 7,500 shares at $90.00 100% of stakeTraded Nov 25, 2025 Filed Nov 28, 2025
-
David D. Davidar DirectorSale$2.2M 25,000 shares at $86.00 4.6% of stakeTraded Nov 12, 2025 Filed Nov 13, 2025
-
Stephen T. Zarrilli DirectorSale$2.1M 25,000 shares at $84.29 100% of stakeTraded Nov 11, 2025 Filed Nov 13, 2025
-
Ann D. Rhoads DirectorPlanned sale$818K 10,000 shares at $81.80 39% of stakeTraded Nov 7–10 Filed Nov 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 17 option exercises and 1 gift.
SEC filings
Recent issuer filings from EDGAR, 16 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.02,5.07,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon
- Financial Intelligence, Revised Ed. View on Amazon